NitiNotes

Summary: Founded in 2014, Nitinotes Ltd. is developing breakthrough, minimally invasive devices for the multi-billion dollar obesity market. Our concept is to convert laparoscopic sleeve gastrectomy to an operator-friendly endoscopic procedure that reduces the stomach volume internally. Nitinotes will introduce an innovative disposable toolset reinventing the technique, so that it may be applied to a much greater patient population, to be performed by gastroenterologists as well as surgeons, in the outpatient clinic,]] without the need for general anesthesia, and at much lower cost. Our procedure creates an effect of stomach volume restriction and motility impair.

Need: One of the biggest health stories of the year has been the rise in obesity among both adults and children in the U.S. Today, there are no effective anti-obesity drugs. The gold standard treatment available is a highly invasive surgical procedures that irreversibly reconfigures the GI anatomy. Not surprisingly, the vast majority of people do not seek this option. Just over 2% of the people who need obesity treatment undergo surgery each year.

Value: Today, there are no effective anti-obesity drugs. The gold standard treatment available is a highly invasive surgical procedures that irreversibly reconfigures the GI anatomy. Not surprisingly, the vast majority of people do not seek this option. Just over 2% of the people who need obesity treatment undergo surgery each year. Nitinotes will offer an effective, yet minimally invasive obesity solution; Nitinotes is presenting a novel technique to convert laparoscopic sleeve gastrectomy to an operator-friendly endoscopic procedure generating an internal gastric sleeve transorally.